Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy.

J Matern Fetal Neonatal Med

Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Houston Medical School, Houston, Texas 77030, USA.

Published: August 2005

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias. In many patients the disease is familial. ARVC may account for as many as 5% of unexpected sudden deaths. We report a case of ARVC diagnosed at 21 weeks gestation treated with an implantable cardiac defibrillator. The remainder of her pregnancy was uneventful and the patient underwent induction of labor at 39 weeks gestation with a passive second stage forceps-assisted delivery resulting in delivery of a normal infant. In the gravida with cardiac arrhythmias, defibrillator placement may offer a safe, life-preserving treatment and should be considered.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14767050500226500DOI Listing

Publication Analysis

Top Keywords

arrhythmogenic ventricular
8
ventricular cardiomyopathy
8
defibrillator placement
8
weeks gestation
8
cardiomyopathy implantable
4
implantable cardioverter
4
cardioverter defibrillator
4
placement pregnancy
4
pregnancy arrhythmogenic
4
cardiomyopathy arvc
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!